Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

People with alopecia areata have higher insulin resistance.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Higher CRBP1 levels are linked to more severe alopecia areata.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

New treatments for alopecia areata focus on targeted drugs and regenerative therapies, but challenges remain.

Vitamin D may help with certain types of hair loss in women.

Both treatments for alopecia areata showed similar modest effectiveness.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Children with alopecia areata often face more stress and depression, especially related to separation, which can affect their condition.

Trichoscopy helps correctly diagnose alopecia areata, not syphilitic alopecia, in patients with recent syphilis.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Collagen XXII is a marker for tissue junctions, aiding in structural integrity and found in muscles, heart, skin, and arthritic joints.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.